Role of intracellular signaling events in ADP-induced platelet aggregation

Thrombosis and Haemostasis

Volumn 82, Issue 4, 1999, Pages 1322-1326

  James L, Daniel ^b   Dangelmaier, Carol ^b   Jin, Jianguo ^b   Kim, Young B ^b   Kunapuli, Satya P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYADENOSINE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,3,4 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHOLIPASE C;

ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0344200064     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614384     Document Type: Article

References (25)

1. Holmsen H, Weiss HJ. Secretable storage pools in platelets. Annu Rev Med 1979; 30: 119-34.
2. Gachet C, Hechler B, Leon C. Vial C, Leray C, Ohlmann P, Cazenave JP. Activation of ADP receptors and platelet function. Thromb Haemost 1997; 78: 271-5.
3. Mills DC. ADP receptors on platelets. Thromb Haemost 1996; 76: 835-56.
4. Kunapuli SP. Multiple P2 receptor subtypes on platelets: A new interpretation of their function. Trends in Pharmacological Sci 1998; 19: 391-4.
5. Bennett JS, Chan C, Vilaire G, Mousa SA, DeGrado WF. Agonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem 1997; 272: 8137-40.
6. Gordon J. Extracellular ATP: effects, sources and fates. Biochem J 1986; 233: 309-19.
7. MacKenzie AB, Mahaut-Smith MP, Sage SO, Nakamura F, Amieva MR, Furthmayr H. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets. Journal of Biological Chemistry 1996; 270: 31377-85.
8. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998; 273: 2024-9.
9. Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998; 273: 2030-4.
10. Fagura MS, Dainty IA, McKay GD, Kirk IP, Humphries RG, Robertson MJ, Dougall IG, Leff P. P2y(1)-receptors in human platelets which are pharmacologically distinct from P2y(ADP)-receptors. British Journal of Pharmacology 1998; 124: 157-64.
11. Geiger J, Honigliedl P, Schanzenbacher P, Walter U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. European Journal of Pharmacology 1998; 351: 235-46.
12. Hechler B. Leon C, Vial C, Vigne P, Frelin C, Cazenave JP, Gachet C. The P2y(1) receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. Blood 1998; 92: 152-9.
13. Jantzen H-M, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds E, Conley PD. Evidence for two distinct G protein-coupled ADP receptors mediating platelet activation. Thromb Haemost 1998; 81: 111-7.
14. Boyer JL, Romeroavila T. Schachter JB, Harden TK. Identification of competitive antagonists of the P2y(1) receptor. Mol Pharmacol 1996; 50: 1323-9.
15. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-4.
16. Savi P, Beauverger P, Labouret C, Delfaud M, Salel V, Kaghad M, Herbert JM. Role of P2YI purinoceptor in ADP-induced platelet activation. FEBS Lett 1998; 422: 291-5.
17. Savi P, Bornia J, Salel V, Delfaud M, Herbert JM. Characterization of P2x1 purinoreceptors on ral platelets - Effect of clopidogrel. British Journal of Haematology 1997; 98: 880-6.
18. Salzman EW. Cyclic AMP in platelet function. New Engl J Med 1972; 286: 358-63.
19. Haslam RJ, Davidson MM. Desjardins JV. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic. AMP Biochem J 1978; 176: 83-95.
20. Gabbeta J, Yang X, Sun L, McLane MA, Niewiarowski S, Rao AK. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. Blood 1996; 87: 1368-76.
21. Daniel JL, Dangelmaier CA, Smith JB. Formation and metabolism of inositol 1,4,5-trisphosphate in human platelets. Biochem J 1987; 246: 109-14.
22. Locati M, Murphy PM. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS [In Process Citation]. Annu Rev Med 1999; 50: 425-40.
23. van Willigen G, Donath J, Lapetina EG, Akkerman JW. Identification of alpha-subunits of trimeric GTP-binding proteins in human platelets by RT-PCR. Biochem Biophys Res Commun 1995; 214: 254-62.
24. Offermanns S, Hu YH, Simon MI. Galpha12 and galpha13 are phosphorylated during platelet activation. Journal of Biological Chemistry 1996; 271: 26044-8.
25. Klages B, Brandt U, Simon MI, Schultz G, Offermanns S. Activation of G12/G13 results in shape change and Rho/Rho-Kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 1999; 144: 745-54.